1. Takei, I., Sumida, T., and Taniguchi, M.: Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor.
J. Exp. Med. 158:1912-1923, 1983. (10.892）

2. Taniguchi, M., Kanno, M., Tokuhisa, T., Tagawa, M., Sumida, T., Takei, I., Ono, K., and Shigemoto, K. An antigen-specific suppressor T cell factor composed of two distinct polypeptide chains. In Humoral factors in host defence. ed. by Y. Yamamura, H. Higashi, T. Honjo, T. Kishimoto, M. Muramatsu, and T. Osawa. Academic Press:71-79, 1983.

3. Taniguchi, M., Tokuhisa, T., Saito, T., Takei, I., Sumida, T., Kanno, M., Tagawa, M., Ono, K., Itoh, T., Uematsu, Y., Shigemoto, K., Iemoto, Y., and Imai, K. Molecular aspects of the regulation of immune response. In Progress in Immunology V. ed. by Y. Yamamura and T. Tada. Academic Press:861-870, 1983.

4. Taniguchi, M., Takei, I., Sumida, T., Kanno, M., Tagawa, M., and Itho T. Suppressor T-cell hybridoma with a receptor recognizing KLH-specific suppressor factor. In: The biology of idiotypes. ed. by M. I. Greene and A. Nisonoff. Plenum Press, p.435-447, 1984.

5. Taniguchi, M., Takei, I., and Sumida, T. Restriction elements in the regulatory T cell interactions. In: Immunogenetics- its applications to clinical medicine. eds. by Sasazuki,T., and Tada, T. Academic Press, New York, p.203-210, 1984.

6. Sumida, T., Takei, I., and Taniguchi, M. Activation of acceptor-suppressor hybridoma with antigen-specific suppressor T cell factor of two-chain type: Requirement of the antigen- and the I-J restricting-specificity. J. Immunol. 133:1131-1136, 1984.(4.718)

7. Taniguchi, M., Saito, T., Kanno, M., Tokuhisa, T., Sumida, T., and Tagawa, M. Antigen-specific suppressor T cell factor: Functional and molecular structure. In T cell hybridomas. ed. by M. J. Taussing. CRC Press Inc., p. 197-208, 1985.

8. Sumida, T., and Taniguchi, M. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
J. Immunol. 134:3675-3681, 1985.(4.718)

9. Taniguchi, M., and Sumida, T. The I-J as an idiotypic marker on the antigen-specific suppressor T cell factor. Immunol Rev. 83:125-150, 1985.(11.292)

10. Taniguchi, M., and Sumida, T. Regulatory T cell interactions mediated by antigen-specific suppressor T cell factors. In T cell clones. ed. by H. von Bohmer and W. Haas. Elsevier, Amsterdom, p. 55-65, 1985.

11. Sumida, T., Sado, T., Kojima, M., Ono, K., Kamisaku, H., and Taniguchi, M. The "I-J" as an idiotype of recognition component of antigen-specific suppressor T cell factor.
Nature 316:738-741, 1985.(43.070)

12. Taniguchi, M., Sumida, T., Ono, K., and Sado, T. Antigen-specific and MHC-restricted suppression of antibody response induced by monoclonal antibody. Cellular and Molecular Biology of Lymphokines. p. 11-20, 1985.

13. Taniguchi, M., Imai, K., Matsushita, E., Sumida, T., Tagawa, M., Yamamoto, S., and Kanno, M. Antigen-receptor and functional molecule of suppressor T cell. The Sino-Japanese Journal of Allergology and Immunology (Soshiran) 3: 225-229, 1986.

14. Taniguchi, M., Sumida, T., Imai, K., Kanno, M., and Shigemoto, K. Anti-idiotypic suppressor T cells that express a stereocopy of the modified suppressor epitope on the nominal antigen. In immunogenicity of protein antigens: Repertoire and Regulation: ed. by E. Sercarz and J. Berzofsky. CRC Press. Boca Raton, Florida, USA, p.129-135, 1987.

15. Imai, K., Sumida, T., Kanno, M., Shigemoto, K., and Taniguchi, M. Functional and molecular properties of anti-idiotypic receptor on suppressor T cell-expression of alpha chain gene in Ts hybridoma: In New Horizons in Animal Models for Autoimmune disease, Academic Press, p. 141-148, 1987.

16. Taniguchi, M., Matsushita, E., Imai, K., Koseki, A., Sumida, T., Takemori, T., Itoh, T., Yamamoto, S., and Kanno, M. Suppressor T cell receptor and functional molecule. Molecular Basis of Lymphokine Action ed. by Webb, D., Pierce, C., and Cohen, S. The Human Press Inc., New Jersey, N. Y., p. 13-20, 1987.

17. Fujita, T., Sumida, T., Yoshida, S., Ito, S., and Tamura, N. C4 nephritic factor in a patient with chronic glomerulonephritis. J. Clin. Lab. Immunol. 22:65-70, 1987.

18. Ruther, U., Muller, W., Sumida, T., Tokuhisa, T., Rajewsky, K., and Wagner, F.E. c-fos expression interferes with thymus development in transgenic mice.
Cell 53:847-856, 1988.(36.216)

19. Matsushita, E., Sumida, T., Tagawa, M., and Taniguchi, M. Biochemical characterization of an antigen-specific suppressor T cell factor. Int. Arch. Allergy Appl. Immunol. 88:323-331, 1989.

20. Hiruma, K., Koike, T., Nakamura, H., Sumida, T., Maeda, T., Tomioka, H., Yoshida, S., and Fujita, T. Somatostatin receptors on human lymphocytes and leukaemica cells.
Immunology 71:480-485, 1990.(4.147)

21. Sumida, T., Maeda, T., Koike, T., Tomioka, H., Yoshida, S., Taniguchi, M., and Rajewsky, K. Expression of IgH promoter/enhancer Lyt-1 transgene in hematopoietic chimeric mice generated by embryonic stem (ES) cell line. Int. Arch. Allery Appl. Immunol. 93:155-164, 1990.

22. Maeda, T., Sumida, T., Kurasawa, K., Tomioka, H., Itoh, I., Yoshida, S., and Koike, T. T-lymphocyte-receptor repertoire of infiltrating T lymphocytes into NOD mouse pancreas.
Diabetes 40:1580-1585, 1991.(7.199)

23. Sumida, T., Yonaha, F., Maeda, T., Tanabe, E., Koike, T., Tomioka, H., and Yoshida, S. T cell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients.
J. Clin. Invest. 89:681-685, 1992.(12.282)

24. Sumida, T., Maeda, T., Koike, T., Tomioka, H., Yoshida, S. and Taniguchi, M. Basic studies on germline transmission of ES-derived genes. In: Molecular approaches to the study and treatment of human diseases, eds. by T. O. Yoshida and J. M. Wilson. Elsevier Science Publishers, p.339-346, 1992.

25. Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., Suzuki, T., Sumida, T., Yasuda, T., and Koike, T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.
J. Immunol. 148:3885-3891, 1992.(4.718)

26. Sumida, T., Maeda, T., Takahashi, H., Yoshida, S., Yonaha, F., Sakamoto, A., Koike, T., Tomioka, H., and Yoshida, S. Predominant expansion of Vg9/Vd2 T cells in a tularemia patient. Infect. Immun. 60:2554-2558, 1992.(3.160)

27. Sakamoto, A., Sumida, T., Maeda, T., Itoh, M., Asai, T., Takahashi, H., Yoshida, S., Koike, T., Tomioka, H., and Yoshida, S. Restricted usage of Vb genes on double negative ab T cells in patients with systemic sclerosis. Arthritis Rheum. 35:944-948, 1992.(9.002)

28. Hashimoto, Y., Kawamura, M., Ichikawa, K., Suzuki, T., Sumida, T., Yoshida, S., Matsuura, E., Ikehara, S., and Koike, T. Anticardiolipin antibodies in NZX x BXSB F1 mice - a model of antiphospholipid syndrome -. J. Immunol. 149:1063-1068, 1992.(4.718)

29. Ichikawa, K., Suzuki, T., Hashimoto, Y., Sumida, T., Tomioka, H., Yoshida, S., and Koike, T. Polyspecific nature of monoclonal hybridoma anticardiolipin antibodies derived from SLE mice. Lupus 1:239-247, 1992.(2.924)

30. Yonaha, F., Sumida, T., Maeda, T., Tomioka, H., Koike, T., and Yoshida, S. Restricted junctional usage of T cell receptor V_2 and V_13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjogren's syndrome. Arthritis Rheum. 35:1362-1367, 1992.(9.002)

31. Kurasawa, K., Sakamoto, A., Maeda, T., Sumida, T., Itoh, I., Tomioka, H., Yoshida, S., and Koike, T. Short-term administration of monoclonal anti-L3T4 antibody prevents diabetes in NOD mice. Clin. Exp. Immunol. 91:376-380, 1993.(3.711)

32. Kita, Y., Sumida, T., Ichikawa, K., Maeda, T., Yonaha, F., Iwamoto, I., Yoshida, S., and Koike, T. V gene analysis of anticardiolipin antibodies from MRL-lpr/lpr mice. J. Immunol. 151:849-856, 1993.(4.718)

33. Sumida, T., Yonaha, F., Maeda, T., Kita, Y., Iwamoto, I., Koike, T., and Yoshida, S. Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjogren's syndrome. Arthritis Rheum. 37:545-550, 1994.(9.002)

34. Sumida, T., Sakamaki, T., Yonaha, F., Maeda, T., Namekawa, T., Nawata, Y., Takabayashi, K., Iwamoto, I., and Yoshida, S. HLA-DR alleles in patients with Sjogren's syndrome overrepresenting Vb2 and Vb13 genes in the labial salivary glands. Br. J. Rheum. 33:420-424, 1994.(5.149)

35. Sumida, T., Kita, Y., Yonaha, F., Maeda, T., Iwamoto, I., and Yoshida, S. T cell receptor Va repertoire of infiltrating T cells in the labial salivary glands from patients with Sjogren's syndrome.
J. Rheumatol. 21:1655-1661, 1994.(3.634)

36. Kita, Y., Sumida, T., Iwamoto, I., Yoshida, S., and Koike, T. V gene analysis of anticardiolipin antibodies from (NZW x BXSB)F1 mice. Immunology 82:494-501, 1994.(4.147)

37. Sumida, T., Yonaha, F., Maeda, T., Iwamoto, I., and Yoshida, S. T cell receptor V_ repertoire of infiltrating T cells in the labial salivary glands of patients with Sjogren's syndrome. In Sjogren's syndrome-State of Art, ed. by M. Homma, S. Sugai, T. Tojo, N. Miyasaka and M. Akizuki, Kugler Publications, Amsterdam/New York, p. 455-457, 1994.

38. Yonaha, F., Maeda, T., Kita, Y., Iwamoto, I., Yoshida, S., and Sumdia, T. Restricted junctional usage of T cell receptor Vb2 and Vb13 genes overrepresented on infiltrating T cells in the labial salivary glands of patients with Sjogren's syndrome. In Sjogren's syndrome-State of Art, ed. by M. Homma, S. Sugai, T. Tojo, N. Miyasaka and M. Akizuki, Kugler Publications, Amsterdam/New York, p. 537-539, 1994.

39. Kita, Y., Yonaha, F., Maeda, T., Iwamoto, I., Yoshida, S., and Sumida, T. T cell receptor Va repertoire of infiltrating T cells in labial salivary glands from patients with Sjogren's syndrome. In Sjogren's syndrome-State of Art, ed. by M. Homma, S. Sugai, T. Tojo, N. Miyasaka and M. Akizuki, Kugler Publications, Amsterdam/New York, p. 541-543, 1994.

40. Furukawa, M., Maeda, T., Nawata, Y., Takabayashi, K., Iwamoto, I., Yoshida, S., and Sumida, T. HLA-DR alleles in patients with Sjogren's syndrome overrepresenting Vb2 and Vb13 genes in the labial salivary glands. In Sjogren's syndrome-State of Art, ed. by M. Homma, S. Sugai, T. Tojo, N. Miyasaka and M. Akizuki, Kugler Publications, Amsterdam/New York, p. 483-485, 1994.

41. Namekawa, T., Yonaha, F., Iwamoto, I., Yoshida, S., and Sumida, T. Preferential expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of patients with Sjogren's syndrome. In Sjogren's syndrome-State of Art, ed. by M. Homma, S. Sugai, T. Tojo, N. Miyasaka and M. Akizuki, Kugler Publications, Amsterdam/New York, p. 499-501, 1994.

42. Sumida, T., Furukawa, M., Sakamoto, A., Namekawa, T., Maeda, T., Zijlstra, M., Iwamoto, I., Koike, T., Tomioka, H., and Taniguchi, M. Prevention of insulitis and diabetes in b2-microglobulin-deficient NOD mice. Int. Immunol. 6:1445-1449, 1994.(4.168)

43. Sakamoto, A., Furukawa, M., Iwamoto, I., Koike, T., Tomioka, H., and Sumida, T. T cell receptor Vb repertoire of regulatory T cells in anti-L3T4 antibody treated NOD mice. Immunology 83:540-544, 1994.(4.147)

44. Yumoto, N., Araki, A., Sumida, T., Saito, T., Taniguchi, M., and Mikata, A. Restricted Vb gene usage of tumor-infiltrating lymphocytes in primary gastric malignant B-cell lymphoma. Virchow Arch. 426:11-18, 1995.(2.868)

45. Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K., Iwamoto, I., and Taniguchi, M. Selective reduction of T cells bearing invariant Va24JaQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182: 1163-1168, 1995.(10.892)

46. Murata, H., Kita, Y., Sakamoto, A., Matsumoto, I., Matsumura, R., Sugiyama, T., Sueishi, M., Takabayashi, K., Iwamoto, I., Saitoh, Y., Nishioka, K., and Sumida, T. Limited T cell receptor repertoire of infiltrating T cells in the interstitial nephritis of patients with Sjogren's syndrome. J. Immunol. 155: 4084-4089, 1995.(4.718)

47. Namekawa, T., Kuroda, K., Kato, T., Yamamoto, K., Murata, H., Sakamaki, T., Nishioka, K., Iwamoto, I., and Sumida, T. Identification of Ro/SS-A 52kD reactive T cells in labial salivary glands from patients with Sjogren's syndrome. J. Rheumatol. 22:2092-2099, 1995.(3.634)

48. Matsumoto, I., Tsubota, K., Satake, Y., Kita, Y., Murata, H., Namekawa, T., Nishioka, K., Iwamoto, I., Saitoh, Y., and Sumida, T. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J. Clin. Invest 97: 1969-1977, 1996.(12.282)

49. Nishioka, K., Sumida, T., and Hasunuma, T. Human T cell leukemia virus type-1 in arhtropathy and autoimmune disorders (review). Arthritis Rheum. 39: 1410-1418, 1996.(9.002)

50. Hoa, T. T-M., Hasunuma, T., Aono, H., Masuko, K., Kobata, T., Yamamoto, K., Sumida, T., and Nishioka, K. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J. Rheumatol. 23: 1332-1337, 1996.(3.634)

51. Sumida, T., and Maeda, T. Reply to letter by Venables, et al. Arthritis Rheum. 36: 1611, 1996.(9.002)

52. Fujisawa, K., Asahara, H., Okamoto, K., Hasunuma, T., Kobata, T., Iwakura, Y., Yonehara, S., Sumida T., and Nishioka, K. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I tax transgenic mice. J. Clin. Invest. 98: 271-278, 1996.(12.282)

53. Furukawa, M., Sakamoto, A., Kita Y., Tsubata, R., Tsubata, T., Ohishi, Y., Matsumura, R., Iwamoto, I., Saitoh, Y., and Sumida, T. T cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands, and kidneys from alymphoplasia (aly) mutant mouse-a new model of Sjogren's syndrome. Br. J. Rheumatol. 35: 1223-1230, 1996.(5.149)

54. Asahara, H., Hasunuma, T., Kobata, T., Okumura, K., Yagita, H., Inoue, H., Sumida, T., and Nishioka, K. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin. Immun. Immunopath. 81: 27-34, 1996.(3.548)

55. Hasunuma, T., Hoa, T. T-M., Aono, H., Yonehara, S., Yamamoto, K., Sumida, T., Steffen, G., and Nishioka, K. Induction of Fas-dependent apoptosis in cells of synovial tissues in rheumatoid arthritis. Int. Immunol. 8: 1595-1602, 1996.(4.168)

56. Sumida, T., Namekawa, T., Maeda, T., and Nishioka, K. New T-cell epitope of Ro/SS-A 52kD protein in labial salivary glands from patients with Sjogren's syndrome. Lancet 348:1667, 1996.(59.102)

57. Tsubata, R., Tsubata, T., Hiai, H., Shinkura, R., Matsumura, R., Sumida, T., Miyawaki, S., Kumagai, S., Nakao, K., and Honjo, T. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome. Eur. J. Immunol. 26: 2742-2748, 1996.(4.695)

58. Hasunuma, T., Kayagaki, N., Asahara, H., Motokawa, S., Kobata, T., Aono, H., Sumida, T., Okumura, K., and Nishioka, K. Accumulation of soluble Fas inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 40: 80-86, 1997.(9.002)

59. Asahara, H., Hasunuma, T., Kobata, T., Inoue, H., M殕ler-Ladner, U., Gay, S., Sumida,T., and Nishioka, K. In situ expression of protooncogenes and Fas/Fas ligand in the synovium with rheumatoid arthritis. J. Rheumatol. 24: 430-435, 1997.(3.634)

60. Sumida, T., Matsumoto, I., Murata, H., Namekawa, T., Matsumura, R., Tomioka, H., Iwamoto, I., Saito, Y., Mizushima, Y., Hasunuma, T., Maeda, T., and Nishioka, K. T cell receptor of Fas-sensitive T cells in labial salivary glands of patients with Sjogren's syndrome. J. Immunol. 158:1020-1025, 1997.(4.718)

61. Sumida, T., Hoa, T. T-M, Asahara, H., Hasunuma, T., and Nishioka, K. T cell receptor of Fas-sensitive T cells in rheumatoid synovium. J. Immunol. 158:1965-1970, 1997.(4.718)

62. Okamoto, K., Fujisawa, K., Hasunuma, T., Kobata, T., Sumida, T., and Nishioka, K. Selective tyrosine phosphorylation of JNK in rheumatoid arthritis synoviocytes induced by anti-Fas antibody. Arthritis Rheum. 40:919-926, 1997.(9.002)

63. Sumida, T., Matsumoto, I., Maeda, T., and Nishioka, K. T cell receptor in Sjogren's syndrome (review). Br. J. Rheumatol. 36: 622-629, 1997.(5.149)

64. Xue, C., Takahashi, M., Hasunuma, T., Aono, H., Yamamoto, K., Yoshino, S., Sumida, T., and Nishioka, K. Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and clondrocytes. Ann. Rheum. Dis. 56:262-267, 1997.(14.299)

65. Asahara, H., Fujisawa, K., Kobata, T., Hasunuma, T., Maeda, T., Asanuma, M., Ogawa, N., Inoue, H., Sumida, T., and Nishioka, K. Direct evidence of High DNA-binding activity of transcription factor AP-1 in the synovium with RA. Arthritis Rheum. 40:911-917, 1997.(9.002)

66. Xue, C., Maeda, T., Hasunuma, T., Fujisawa, K., Okamoto, K., Dong, Y., Sumida, T., and Nishioka, K. BFGF-induced proliferation of fibroblasts from RA synovium is mediated by the homeodomain transcription factor. Arhritis Rheum. 40:1628-1635, 1997.(9.002)

67. Sumida, T., Matsumoto, I., Kato, T., Hasunuma, T., Maeda, T., and K. Nishioka. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. 40: 2271-2273, 1997.(9.002)

68. Hasunuma, T., Sumida, T., and Nishioka, K. Human T cell leukemia virus type-1 and rheumatoid arthritis. In International Review of Immunology, ed. by T. Sasaki, Harwood Academic Publishers, Int Rev Immunol. 17:291-307, 1998.(3.481)

69. Nishioka, K., Hasunuma, T., Kato, T., Sumida, T., and Kobata, T. Apoptosis in rheumatoid arthritis: A novel pathway in regulation of synovial tissue (review).
Arthritis Rheum. 41: 1-9, 1998.(9.002)

70. Fujisawa, K., Okamoto, K., Murata, H., Hasunuma, T., Sumida, T., and Nishioka, K. Evidence for autoantigens of env/tax proteins in HTLV-I tax transgenic mice. Arthritis Rheum. 41: 101-109, 1998.(9.002)

71. Kita, Y., Kuroda, K., Mimori, T., Hashimoto, T., Yamamoto, K., Iwamoto, I., Saitoh, Y., and Sumida, T. T cell receptor clonotypes in skin lesions from patients with systemic lupus erythematosus. J. Invest. Dermatol. 110:41-46, 1998.(6.290)

72. Sumida, T., Hasunuma, T., Asahara, H., Maeda, T., and Nishioka, K. Rheumatoid arthritis and apoptosis (review). Internal Med. 37: 184-188, 1998.（0.956）

73. Okamoto, K., Asahara, H., Kobayashi, T., Matsuno, H., Hasunuma, T., Kobata, T., Sumida, T., and Nishioka, K. Potential inductin of apoptosis in rheumatoid synovium by Fas ligand gene transfer. Gene Therapy. 5: 331-338, 1998.(3.749)

74. Maeda, T., Webb, D. R., Chen, J., Kobata, T., Hisose, S., Shirai, T., Takabayashi, K., Nishioka, K., and Sumida, T. Deletion of signaling molecule gene resembling the cytoplasmic domain of Igb in autoimmune prone mice. Int. Immunol. 10: 815-821, 1998.(4.168)

75. Imamura, F., Aono, H., Hasunuma, T., Sumida, T., Tateishi, H., Maruo, S., and Nishioka, K. Monoclonality of synoviocytes are responsible for rapid progression of bone destruction in rheumatoid arthritis. Arthritis Rheum. 41: 1979-1986, 1998.(9.002)

76. Matsumura, R., Umemiya, Kagami, M., Tomioka, H., Tanabe, E., Sugiyama, T., Sueishi, M., Nakajima, A., Azuma, M., Okumura, K., and Sumida, T. Glandular and ectraglandular expression of Fas-Fas ligand and apoptosis in patients with Sjogren's syndrome. Clin. Exp. Rheumatol. 16: 561-568, 1998.(3.238)

77. Sumida, T., Maeda, T., Taniguchi, M., Nishioka, K., and Stohl, W. TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus.
Lupus 7:565-568, 1998.(2.924)

78. Akimoto, T., Akama, T., Kono, I., Yamane, K., and Sumida, T. Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoanticodies. J. Rheumatol. 26: 580-587, 1999.(3.634)

79. Maeda, T., Keino, H., Asahara, H., Taniguchi, M., Nishioka, K., and Sumida, T. Decreased TCR AV24AJ18+ double negative T cells in rheumatoid synovium. Br. J. Rheumatol. 38:186-188, 1999.(5.149)

80. Kobayashi, T., Okamoto, K., Kobata, T., Hasunuma, T., Sumida, T., and Nishioka, K. TNF_ regulates Fas-mediated apoptosis signaling pathway in synovial cells.
Arthritis Rheum. 42:519-526, 1999.(9.002)

81. Uehara, R., Fujisawa, K., Kezuka, T., Sakai, J.-I., Nishioka, K, Sumida, T., and Usui, M. Conserved TCR CDR3 region of infiltrating T cells in experimental autoimmune uveoritinitis.
Ophth. Research 31:249-255, 1999.(1.685)

82. Sumida, T. Sjogren's syndrome. Int. Medicine. 38:165-168,1999.(0.956)

83. Saitoh, I., Haruta, K., Shimura, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda,T., Hayashi, Y., and Tsubota, K. Fas-ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162:2488-2494, 1999.(4.718)

84. Usui, J., Takemura, H., Yuhara, T., Akama, T., Suzuki, H., Yamane, K., and Sumida, T. Dieulafoy's lesion of the esophagus as a probable complication of Takayasu's arteritis. J. Rheumatol. 26: 454-456, 1999.(3.634)

85. Suzuki, M., Katsube, Y., Suzuki, H., Takemura, H., and Sumida, T. Cloning and analysis of anti-double strand DNA IgG autoantibodies obtained by a phage-display method. Int. J. Mol. Med. 3:385-390, 1999.(2.928)

86. Keino, H., Matsumoto, I., Okada, S., Kurokawa, M., Kato, T., Tokuhisa, T., Taniguchi, M., Nishioka, K., and Sumida, T. A single cell analysis of TCR AV24AJ18+ DN T cells. Microbiol. Immunol. 43:577-584, 1999.(1.442)

87. Matsumoto, I., Maeda, T., Takemoto, Y., Hashimoto, Y., Kimura, F., Iwamoto, I., Saito, Y., Nishioka, K., and Sumida, T. a-amylase function as salivary glands-specific self T cell epitopes in patients with Sjogren's syndrome. Int. J. Mol. Med. 3:485-490, 1999.(2.928)

88. Kitagawa, M., Mitsui, H., Nakamura, H., Yoshino, S., Miyakawa, S., Ochiai, N., Onobori, M., Suzuki, H., and Sumida, T. Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals. Arthritis Rheum. 42:1917-1926, 1999.(9.002)

89. Murata, H., Nakauchi, H., and Sumida, T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet. 354:220,1999.(59.102)

90. Matsumoto, I., Okada, S., Kuroda, K., Iwamoto, I., Saito, Y., Tokuhisa, T., Nishioka, K., Sumida, T. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. Int. J. Mol. Med. 4:519-527, 1999.(2.928)

91. Akimoto, T., Akama, T., Kono, I., and Sumida, T. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome. LUPUS 8:761-766, 1999.(2.924)

92. Wang, M., Keino, H., Matsumoto, I., Kurokawa, M., Kato, T., Nishioka, K., and Sumida, T. A single cell analysis of Fas-ligand positive T cells in rheumatoid synovium.
J. Rheumatol. 27:311-318, 2000.(3.634)

93. Yin, W., Hasunuma, T., Kobata, T., Sumida, T., and Nishioka, K. Synovial hyperplasia in HTLV-1 associated arthropathy is induced by tumor necrosis factor-alpha produced by HTLV-1 infected CD68+ cells. J. Rheumatol. 27: 874-881, 2000.(3.634)

94. Enomoto, M., Takemura, H., Suzuki, M., Yuhara, T., Akama, T., Yamane, K., Sumida, T. Palmar Fasciitis and polyarthritis associated with gastric carcinoma: a paraneoplastic syndrome. (Case report). Int. Medicine. 39(9):754-7,2000.(0.956)

95. Yuhara, T., Takemura, H., Akama, T., Yamane, K., and Sumida, T. The relationship between serum immunoglobulin and pulmonary involvement in systemic sclerosis.
J.Rheumatol. 27:1207-1214, 2000(3.634)

96. Suzuki, M., Takemura, H., Suzuki, H., and Sumida, T. Light chain determines the fine specificity of anti-dsDNA IgG autoantibodies obtained by a phage-display method. Biochem. Biophys. Research. Commun. 271: 240-243, 2000.(2.705)

97. Keino, H., Takeuchi, M., Suzuki, J., Sakai, J.-I., Nishioka, K., Sumida, T., and Usui, M. Clonally accumulating ocular T cells n patient with Behcet's disease.
Am. J. Ophthal.130: 243-245, 2000(4.483)

98.Yuhara, T., Takemura, H., Akma, T., Yamane, K., and Sumida, T. Necrotizing fascilitis caused by streptococcus pneumoniae in mixed connective tissue disease.
Modern Rheumatol. 10:180-182,2000.(1.973)

99. Kojo, S., Adachi, Y., Tsutsumi, A., and Sumida, T. Alternative splicing forms of human CD1D gene in mononuclear cells.
Biochem. Biophys. Research. Commun. 276: 107-111, 2000(2.705)

100. Sumida, T. T cell and autoantigens in Sjogren's syndrome (review).
Modern Rheumatol. 10: 193-198, 2000.(1.973)

101. Okamoto, K., Kobayashi, T., Kobata, T., Hasunuma, T., Kato, K., Sumida, T., and Nishioka, K. Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes.
Rheumatology 39: 471-480, 2000(5.149)

102. Morimoto, S., Hashimoto, H., Yamanaka, K., Tokano, Y., Nishimura, Y., Sawada, S., Kamatani, N., Sumida, T., Yoshizaki, K., Nakasawa, K., and Miyasaka, N. The multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus.
Modern Rheumatol. 10: 235-239, 2000.(1.973)

103. Oishi, Y., Sumida, T., Sakamoto, A., Kita, Y., Kurasawa, K., Nawata, Y., Takabayashi, K., Takahashi, H., Yoshida, S., Taniguchi, M., Saito, S., and Iwamoto, I. Selective reduction and recovery of invariant Va24JaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
J. Rheumatol. 28:275-283, 2001.(3.634)

104. Akimoto, T., Akama, T., Saito, M., Kono, i., and Sumida, T. Anti-prothorombin autoantibodies in gestational toxicosis and abortion.
Am. J. Med. 110:188-191, 2001.(4.760)

105. Keino, H., Takeuchi, M., Kojo, S., Suzuki, J., Sakai, J., Nishioka, K., Sumida, T., and Usui, M. Identification of regulatory T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis.
Clin. Exp. Immunol. 124:1-8, 2001(3.711)

106. Kojo, S., Adachi, Y., Keino, H., Taniguchi, M., and Sumida, T. Dysfunction of TCR AV24AJ18+BV11+ double negative regulatory NKT cells in autoimmune diseases.
Arthritis Rheum. 44(5):1127-1138, 2001(9.002)

107. Tsutsumi, A., Sasaki, K., Wakamiya, N., Ichikawa, K., Atsumi, T., Ohtani, K., Suzuki, Y., Koike, T., and Sumida, T. Mannose binding lectin gene: Polymorphisms in japanese patients with systemic lupus erythematosus, rheumatoid arthritis and sjogren's syndrome.
Genes Immun.2(2):99-104, 2001.(2.631)

108. Kitagawa, M., Suzuki, H., Adachi, Y., Nakamura H., Yoshino, S., and Sumida, T. Interferon-gamma enhances interleukin-12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways.
J. Rheumatol. 28(8):1764-1771,2001(3.634)

109. Shimizudani, N., Murata, H., Kojo, S., Adachi, Y., Keino, H., Tsuchida, F., Sumida, M., Kawamata, M., Sumida, T., Matsuoka, K. Analysis of T cell receptor Vbeta gene expression and clonality in bronchoalveolar fluid lymphocytes from a patient with chronic eosinophilic pneumonitis.
Lung 179:31-41, 2001(2.231)

110. Murata, H., and Sumida, T. Quantitative analysis of fetal michrochimerism in Japanese women with systemic sclerosis.
Mod. Rheumatol. 11:259-260, 2001.(1.973)

111. Kurata, M., Nozue, M., Seino, K.-I., Murata, H., Sumida, T., and Fukao, K. Indications for surgery in intestinal Behcet's disease.
Hepatogastroenterology. 53(67):60-3,2006(0.792)

112. Shimizudani N., Murata H., Keino H., Kojo S., Nakamura H., Morishima Y., Sakamoto T., Ohtsuka M., Sekizawa K., Sumida M., Sumida T., and Matsuoka T.: Conserved CDR 3 Region of T Cell Receptor BV Gene in Lymphocytes from Bronchoalveolar Lavage Fluid of Patients with Idiopathic Pulmonary Fibrosis. Clin. Exp. Immunol. 129:140-149,2002(3.711)

113. Matsumoto I., and Sumida T.: B cells and Immunoglobulins dependent mechanisms in rheumatoid arthritis.
Therapeutic Apheresis. 6:317-319,2002(1.077)

114. Tsutsumi A., Ebizuka T., Murata H., Takemura H., and Sumida T.: A case of HLA B27 positive coxitis diagnosed 15 years after onset.
Mod. Rheumal. 12:349-353,2002.(1.973)

115. Murata H., Matsumura R., Koyama A., Sugiyama T., Sueishi M., Shibuya K., Tsutsumi A., and Sumida T.: T Cell Receptor of T Cells in the Kidneys of Patients with Lupus Nephritis.
Arthritis Rheum. 46:2141-2147,2002(9.002)

116.Yasukochi T, Ozawa K, Sato M, Tsutsumi A, Sumida T, Shibanaka Y.: Evaluation of the improvement of IGCR technique.
Nucleic Acids Res.Suppl.2:199-200,2002(11.147)

117. Ohnishi Y., Tsutsumi A., and Sumida T.: Antibodies to type II collagen and their association with HLA DR1 alleles in Japanise patients with rheumatoid arthritis. Mod. Rheumatol 13:69-72, 2003.(1.973)

118. Adachi Y., Tsutsumi A., Murata H., Takemura H., Chino Y., Takahashi R., Ebitsuka T., and Sumida T.: Behcet's disease accompanied by myelodysplastic syndrome with trisomy 8: two case reports and review of 15 Japanese cases. Mod Rheumatol. 13:90-94, 2003.(1.973)

119.Ohnishi Y., Tsutsumi A., Sakamaki T., and Sumida T.:
T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis.
Int. J. Mol. Med . 11:331-335,2003(2.928)

120.Matsumoto I., David M Lee., Raphaela Goldbach-Mansky., Sumida T., Carol A Hitchon., Peter H. Schur., Ron J Anderson., Jonathan S Coblyn., Michael E Weinblatt., Michael Brenner., Bernard Duclos., Jean-Louis Pasquali., Hani El-Gabalawy., Diane Mathis. , and Christophe Benoist.:Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders
Arthritis and Rheumatism 48:944-954, 2003(9.002)

121.Yoshida K., Tsutsumi A., Ohnishi Y., Akimoto T., Murata H., and Sumida T.:T cell epitopes of prothrombin in patients with antiphospholipid syndrome.
Ann. Rheum. Dis. 62:1-2,2003(14.299)

122.Tsutsumi A., Ikegami H., Takahashi R., Murata H., Goto D., Matsumoto I., Fujisawa T., and Sumida T.:
Mannose binding lectin gene polymorphism in patients with type I diabetes.
Human Immunology. 64: 621-624, 2003(2.202)

123. Kojo S., Tsutsumi A., Goto D., and Sumida T.: Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis.
The journal of Rheumatology. 30:2524-2528,2003(3.634)

124.Shibuya K., Shirakawa J., Kameyama T., Honda S.-1., Tahara-Hanaoka S., Miyamoto A., Onodera M., Sumida T., Nakauchi H., Miyoshi H., and Shibuya A.:
CD226(DNAM-1) is involved in LFA-1 costimlatory signal for naive T cell differentiation and proliferation.
J. Exp. Med. 198:1829-1839,2003(10.892)

125.Arakaki R., Ishimaru N., Saito I., Kobayashi M., Yasui N., Sumida T., and Hayashi Y.:
Development of Autoimmune Exocrinopathy Resembling Sjoren's Syndrome in Adoptively Transferred Mice With Autoreactive CD4+T Cells.
Arthritis and Rheumatism. 48:3603-3609,2003(9.002)

126. Murata H., Adachi Y., Ebitsuka T., Chino Y., Takahashi R., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Akaza H., and Sumida T.:
Reiter's syndrome following intravesical Bacille bilie de Calmette-Guerin treatment for superficial bladder carcinoma. Report of six cases
Mod. Rheumatol. 14:82-86,2004.(1.973)

127.Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., Goto D., Matsumoto I.,Murata H., Noguchi E., and Sumida T.:
Polymorphisms of IL-1β Gene in Japanese Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus.
J. Rheumatol.31:720-725,2004(3.634)

128.Tsutsumi A., Adachi Y., Murata H., Kojo S., Shibuya K., Nakamura H., and Sumida T.:
G0S24, a gene that regulates TNFa production,is highly expressed in synovial tissue from patients with rheumatoid arthritis.
J. Rheumatol. 31(6):1044-9,2004(3.634)

129.Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., Ito S., Murata H., Tsutsumi A., Sumida T.:
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies.Possible mechanism of autoantibody production
Biochem. Biophys. Research. Commun.323(2):518-522,2004(2.705)

130.Kato T., Asahara H., Kurokawa MS., Fujisawa K., Hasunuma T., Inoue H., Tsuda M., Takahashi S., Motokawa S., Sumida T., Nishioka K.:
HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.
Clin Rheumatol.23(5)400-9,2004(2.293)

131.Ito S., Sumida T.: Interstitial Lung Disease Associated with Leflunomide.
Intern Med 43(12):1103-1104,2004 (0.9567)

132.Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., Wakamiya N.,and Sumida T.:
Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus.
Clin. Exp. Immunol.136(3):585-590,2004(3.711)

133.Takahashi R., Tsutsumi A., Ohtani K., Muraki Y., Goto D., Matsumoto I., Wakamiya N., and Sumida T.:
Association of mannose-binding lection(MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
Ann. Rheum. Dis.64(2):311-314,2005(14.299)

134.Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., Ito S.,Tsutsumi A., Sumida T.:
Muscariinic acetylcholine recepter auto antibodies in patients with Sjogren's syndrome.
Ann. Rheum. Dis.64(3):510-511,2005(14.299)

135. Tomoo T., Tsutsumi A., Yasukochi T., Ikeda T., Ochiai N., Ozawa K., Shibanaka Y., Ito S., Matsumoto I., Goto D., Sumida T.:
Analysis of abnormally expressed genes in synovium from patients with rheumatoid arthritis using a column gel electrophoresis-coupled subtractive hybridization technique.
Int. J. Mol. Med.15(3):453-457,2005(2.928)

136. Ota M., Mizukami K., Hayashi T., Sumida T., Asada T.:
Brain magnetic resonance imaging and single photon emission computerized tomography findings in a case of relapsing polychondritis showing cognitive impairment and personality changes.
Prog Neuro-psychopharmacol Bio Psychiatry.29(2):347-349,2005(4.315)

137.Ohnishi Y, Tsutsumi A, Goto D, Ito S, Matsumoto I, Taniguchi M, Sumida T.:
TCRVa14+NKT cells function as effector T cells in collagen-induced arthritis mice.
Clin. Exp. Immunol. 141:47-53,2005(3.711)

138.Tsutsumi A, Takahashi R, Sumida T.: Mannose binding lectin:genetics and autoimmune disease.
Autoimmunity Reviews. 4:364-372,2005(7.716)

139.Sumida T.: Comments to the editor concerning paper by Naito, Yet al.
Ann.Rheum.Dis.(in press)(14.299)

140.Suzuki T., Muraki Y., Yasukochi T., Hua Zhang., Kori Y., Wakamatsu E., Hayashi T., Goto D., Ito S., Tsutsumi A., Sumichika H., Sumida T., Matsumoto I.:
Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys
Autoimmunity Reviews 4:475-478,2005(7.716)

141.Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
Clinical Characteristics of Anti-Glucose-6-Phosphate Isomerase Antibodies positive Japanese Patients with Rheumatoid Arthritis
Modern Rheumatoloogy 15:258-263,2005.(1.973)

142.Matsumoto I, Muraki Y, Yasukochi T, Hua Zhang, Kori Y, Hayashi T, Goto D, Ito S, Tsutsumi A, Ikeda K, Sumichika H, Sumida T.:
The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis
Int. J. Mol. Med .16(5):793-800,2005 (2.928)

143.Matsumoto I, Hua Zhang, Muraki Y, Hayashi T, Yasukochi T, Kori Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
A functional variant of Fcy receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals
Arthritis. Res. Ther. 7:1183-1188,2005(4.148)

144.Takahashi R, Tsutsumi A, Ohtani K, Wakamiya N, Sumida T.:
Mannose-binding lectin variant alleles are not a risk factor for arterial thrombosis in Japanese patients with systemic lupus erythematosus
Mod.Rheumatol.(letter)15:459-460,2005.(1.973)

145.Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, Sumida T.:
Altered peptide ligants regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjogren's Syndrome
Ann. Rheum. Dis. 65:269-271,2006(14.299)

146.Miyahara S, Ito S, Soeda A, Chino Y, Hayashi T, Takahashi R, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Intern Med.44(12)1298-1306,2005(0.956)

147.Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T.:
T cell receptor BV gene repertoire in lymphocytes from bronchoalveolar lavage fjuid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
Int. J. Mol. Med. 17:101-109,2006(2.928)

148.Kitagawa M, Goto D, Mamura M, Matsumoto I, Ito S, Tsutsumi A, Sumida T.:
Inhibitory peptides of CD40/CD154 interaction.
Mod.Rheumatol. 15:423-426,2005.(1.973)

149.Kori Y., Matsumoto I., Hua Zhang., Yasukochi T., Hayashi T., Iwanami K., Goto D., Ito S., Tsutsumi A., Sumida T.:
Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
Ann. Rheum. Dis.65:968-969,2006(14.299)

150.Ito S, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Diagnosis of Chlamydia-induced reactive arthritis
Intern Med(letter) 45(1)37-37,2006(0.956)

151.Yoshioka H, Ito S, Handa S, Tomiha S, Kose K, Haishi T, Tsutsumi A,Sumida T.:
Low-fied compact magnetic resonance imaging system for the hand and wrist in rheumatoid arthritis.
JMRI　23(3):370-376,2006(3.732)

152.Suzuki E, Tsutsumi A, Goto D, Matsumoto I, Ito S, Otsu M, Onodera M, Takahashi S, Sato Y, Sumida T.:
Gene transduction of tristetraprolin or its active domain reduces TNF-α production in Jurkat T cells.
Int.J.Mol.Med. 17(5)801-809,2006(2.928)

153.Suzuki E, Hayashi T, Ito S, Miyazaki K, Yamazaki H, Machino T, Takahashi R, Chino Y, Goto D, Matsumoto I, Tsutsumi A, Sato Y, Sumida T.:
A Case of Pulmonary Hypertension Associated with Systemic Lupus Erythematosus without Anti-ribonucleoprotein Antibodies.
ACTA MEDICA et BIOLOGICIA 53(3)87-93,2005

154.Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A.:
Critical role of M.tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice
Immunology 118 233-239,2006(4.147)

155.Sumida T, Wakamatsu E, Nakamura Y, Matsumoto I.:
Autoantibodies against muscarinic acetylcholine receptor in patients with Sjogren's syndrome.(review)
In Textbook of autoantibodies Second Edition, ed. by Y. Shoenfeld, M. E. Gershwin and P. L. Meroni. Elsevier, 681-686, 2007

156.Suzuki E, Tsutsumi A, Sugihara M, Mamura M, Goto D, Matsumoto I, Ito S, Ikeda K, Ochiai N, Sato Y, Sumida T.:
Expression of TNF-α, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synobium of patients with rheumatoid arthritis.
Int.J.Mol.Med. 18:273-278,2006(2.928)

157.Tsutsumi A, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Significnace of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other phospholipids antibody assays.
Mod.Rheumatol.16:158-164,2006.(1.973)

158.Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T.:
Overexpression of phosphorylated stat1-α in labial salivary glands of patients with Sjogren's Syndrome
Arthritis Rheum 54(11)3476-3484,2006(9.002)

159.Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y, Sumida T.:
Altered peptide ligands control type 2 collagen-reactive T cells from RA patients
Mod.Rheumatol.16:226-228,2006.(1.973)

160.Wakamatsu E, Nakamura Y, Matsumoto I, Goto D, Ito S, Tsutsumi A, Sumida T.:
DNA microarray analysis of labial salivary gland of patients with Sjogren's syndrome
Ann. Rheum. Dis. 66:844-845,2007(14.299)

161.Yamada H, Nakagawa Y, Wakamatsu E, Sumida T, Yamachika S, Nomura Y, Mishima K, Saito I.:
Efficacy prediction of cevimeline in patients with Sjogren's syndrome.
Clin Rheumatol. 26:1320-1327,2007(1.973)

162.Yamada H, Ishii W, Ito S, Iwanami K, Ogishima H, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Sarcoid myositis with muscle weakness as a presenting symptom
Mod Rheumatol 17:243-246,2007.(1.973)

163. Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Intern Med 46:771-774, 2007(0.956)

164.Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.:
Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Arthritis Rheum 56(7):2160-2169,2007(9.002)

165.Takana Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T.
A multi-center phase I/II trial of rituximab for refractory systemic lupus erythematosus
Mod.Rheumatol 17(3):191-197,2007.(1.973)

166.Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Sumida T.
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Intern Med 46:1033-1037, 2007(0.956)

167.Hayashi T, Matsumoto I, Yasukochi T, Mamura M, Goto D, Ito S, Tsutsumi A, Sumida T.:
Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis.
Int. J. Mol. Med.20(2):247-253,2007(2.928)

168.Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minoda S, Nara H, Kondo H, Okada J, Mimori t, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y.:
Efficacy and Safety of Mizoribine for Treatment of Sjogren's Syndrome-A Multicenter Open-label Clinical Trial.
Mod.Rheumatol. 17:464-469,2007. (1.973)

169.Kobayashi T, Ito S, Kuroda T, Yamamoto K, Sugita N, Narita I, Sumida T, Gejyo F, Yoshie H.:
The Interleukin-1 and Fcg Receptor Gene Polymorphisms in Japanese Patients with Rheumatoid Arthritis and Periodontitis
J. Periodont. 78(12) : 2311-2318, 2007(2.768)

170.Nakamura Y, Wakamatsu E, Matsumoto I, Tomiita M, Kohno Y, Mori M, Yokota S, Goto D, Ito S, Tsutsumi A, Sumida T.:
High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjogren's syndrome
Ann. Rheum. Dis. 67(1):136-137, 2008(14.299)

171.Tatsumura M, Mishima H, Shiina I, Hara Y, Nishiura Y, Ishii T, Ochiai N, Ishii W, Sumida T.:
Femoral nerve palsy cuased by a huge iliopectineal synovitis extending to the iliac fossa in a rheumatoid arthritis case.
Mod.Rheumatol 18:81-85,2008.(1.973)

172.Matsui H, Tsutsumi A, Sugihara M, Suzuki T, Iwanami K, Kohno M, Goto D, Matsumoto I, Ito S, Sumida T.:
Visfatin(pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis
Ann. Rheum. Dis. 67(4):571-572,2008(14.299)

173.Iwanami K, Matsumoto I, Watanabe Y, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.:
Crucial role of IL-6/IL-17 cytokine axis in the induction of arthritis by glucose-6-phosphate-isomerase.
Arthritis Rheum. 58(3):754-763 ,2008(9.002)

174.Kohno M, Tsutsumi A, Matsui H,Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T.:
Interleukin 17 gene expression in patients with rheumatoid arthritis
Mod.Rheumatol 18:15-22,2008.(1.973)

175.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M, Sumida T.:
Intravascular large B-cell lymphoma with acute abdomen as a presenting symptom in a patient with systemic lupus erythematosus
J. Clin. Oncol. 26(9):1553-1555,2008 (28.245)

176.Wang Y, Ito S, Chino Y, Iwanami K, Yasukochi T, Goto D, Matsumoto I, Hayashi T, Uchida K, Sumida T.:
Use of Laser Microdissection in the Analysis of Renal-infiltrating T cells in MRL/lpr Mice
Mod. Rheumatol 18:385-393,2008. (1.973)

177.Suzuki T, Tsutsumi A, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Tristetraprolin(TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals
Mod. Rheumatol 18:472-479,2008 (1.973)

178.Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, Tsutsumi A, Taniguchi M, Sumida T.:
Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis.
Int.J.Mol.Med. 22:369-374,2008(2.928)

179.Matusmoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Therapeutic effects of antibodies to TNF alpha and IL-6 and CTLA-4 Ig in mice with glucose-6-phosphate isomerase-induced arthritis
Arthritis Res Ther10:R66,2008(4.148)

180.Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S-I.:
Flow cytometric analysis of lymphocyte subpopulations and Th1/Th2 balance in patients with poly myositis and dermatomyositiis.
Intern. Med.47(18)1593-1599,2008(0.956)

181.Kawaguchi Y, Nakamura Y, Matsumoto I, Nishimagi E, Kamatani N, Satoh T, Kuwana M, Sumida T, Hara M.:
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
Ann. Rheum. Dis. 68:710-714,2009(14.299)

182. Ito I, Kawasaki A, Ito S, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Geoffrey Hom, Robert R. Graham, Takasaki Y, Hashimoto H, Ohashi J, Timothy W. Behrens, Sumida T, Tsuchiya N.:
Replication of the Association between C8orf13-BLK Region and Systemic Lupus Erythematosus in a Japanese Population.
Arthritis Rheum. 60(2):553-558,2009(9.002)

183.Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Robert R Graham, Geoffrey Hom, Takasaki Y, Hashimoto H, Timothy W Behrens, Sumida T, Tsuchiya N.:
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of STAT1-STAT4 region.
Arthritis Res Ther 10:R113,2008(4.148)

184.Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
B cell play crucial role as antigen presenting cells and collaborationg with inflammatory cytokines in glucose-6-phoaphate isomerase-induced arthritis.
Clin. Exp. Immunol. 155:285-294,2009(3.711)

185.Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Arthritogenic T cell epitope in glucose-6-phosphate isomerase (GPI)-induced arthritis.
Arthritis Res Ther 10(6):R130. Epub ,2008(4.148)

186.Tsutsumi A, Kobayashi T, Ito S, Goto D, Matsumoto I, Yoshie H, Sumida T.:
Mannose binding lection gene polymorphisms and the severity of chronic periodontitis.
Jap.J.Clin.Immunol 32:48-52,2009

187.Kobayashi T, Murasawa A, Ito S, Yamamoto K, Komatsu Y, Abe A, Sumida T, Yoshie H.
Cytokine gene polymorphisms associated with rheumatoid arthritis and periodontitis in Japanese adults.
J.Periodont. 80:792-799,2009(2.768)

188.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009.(1.973)

189. Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009(0.956)

190.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A new low-field extremity magnetic resonance imaging and proposed compact MRI score: Evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.
Mod Rheumatol 19:358-365,2009.(1.973)

191.Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T.:
Altered peptide ligands regulate type II collagen-induced arthritis in mice
Mod Rheumatol 19:366-371,2009.(1.973)

192.Segawa S, Goto D, Yoshiga Y, Hayashi T, Matsumoto I, Ito S, Sumida T.:
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.
Int. J. Mol. Med.24(4):481-486,2009(2.928)

193.Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, Goto D, Ito S, Sumida T.:
Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
Arthritis Res Ther.11(4):R118. Epub 2009 Aug 6(4.148)

194. Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, Tsutsumi A, Hayashi T, Uchida K, Usui J, Yamagata K,Sumida T.:
Laser Microdissection-based Analysis of Cytokine Balance in the Kidneys of Patients with Lupus Nephritis
Clin. Exp. Immunol. 159(1):1-10,2010(3.711)

195. Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
Ann. Rheum. Dis.69:936-937,2010(14.299)

196.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther.11:R167,2010(4.148)

197.Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.
Intern. Med.49:187-189,2010(0.956)

198.Segawa S, Goto D, Yoshiga Y, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Inhibition of transforming growth factor-b signaling attenuates IL-18 plus IL-2-induced interstitial lung disease in mice.
Clin. Exp. Immunol.160:394-402,2010(3.711)

199.Tashiro T, Nakagawa R, Inoue S, Omori-Miyake M, Chiba T, Fujii S, Shimizu K, Mori K, Yoshiga Y, Sumida T, Watarai H, Taniguchi M.
Induction of Th1-biased cytokine production by α-carba-GalCer,a neoglycolipid ligand for natural killer T cells.
Int.Immunol.22(4):319-328,2010(4.168)

200.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
Mod. Rheumatol. 20(4):331-336,2010.(1.973)

201. Kawasaki A, Ito I, Ito S, Hayashi T, Goto D, Matsumoto I, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
Journal of Biomedicine and Biotechnology.Epub 2010 May 27(2.197)

202.Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I.:
Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjogren's syndrome.
Autoimmunity Reviews 9:615-617,2010(7.716)

203.Ogishima H, Ito S, Tsutsumi A, Sugihara M, Goto D, Matsumoto I, Obata-Yasuoka M,  Hamada H, Yoshikawa H, Takahashi H, Murashima A, Sumida T.:
High dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report
International Journal of Rheumatic Diseases13(3):e32-e35,2010(1.938)

204.Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
Clin. Exp. Immunol. 162:53-61, 2010(3.711)

205.Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T.:
Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
Modern Rheumatology 20:548-555,2010.(1.973)

206.Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M, Li W, Inoue Y, Ackermann K, Shirota H, Matsumoto I, Spyvee M, Schiller S, Sumida T, Gusovsky F, Lamphier M.
A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
Br J Pharmacol. 2010 May;160(2):292-310.(6.583)

207.Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T.:
Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
Modern Rheumatology 20:556-560,2010.(1.973)

208.Doki K, Homma M, Hori T, Tomita T, Hasegawa Y, Ito S, Fukunaga K, Kaneko M, Chiba S, Sumida T, Ohkohchi N, Kohda Y.:
Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.
Journal of Pharmacy and Pharmacology 62(9):1185-1188,2010(2.390)

209.Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S, Hahn BH, Lau YL, Tsao BP.:
Gender Specific Association of X-linked TLR7 with Male Systemic Lupus Erythematosus
PNAS 107(36)15838-15843,2010(9.580)

210.Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
J. Autoimmunity 35:383-389,2010(7.543)

211.Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
Int J Rheum Dis. 14:86-91,2011(1.938)

212.Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham R R, Matsuta K, Behrens T W, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population : a case-control association study.
Arthritis Res. Ther. 12:R174,2010(4.148)

213.Hikami K, Kawasaki A, Ito I, Koga M, Ito S, Hayashi T, Matsumoto I, Tsutsumi A, Kusaoi M, Takasaki Y, Hashimoto H, Arinami T, Sumida T, Tsuchiya N.:
Association of a functional polymorphism in the 3' untranslated region of SPI1 with systemic lupus erythematosus.
Arthritis Rheum. 63:755-763,2011(9.002)

214.Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Tanaka Y, Umeda N, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.:
Comparative suppressive effect in models of autoimmune arthritis by tyrosine kinase inhibitors imatinib and nilotinib.
Mod. Rheumatol 21:267-275,2011.(1.973)

215.Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Involvement of NK 1.1-Positive {gamma}{delta}T Cells in Interleukin-18 Plus Interleukin-2-Induced Interstitial Lung Disease.
Am. J. Res. Cell. Mol. Biol. 45(3):659-666,2011（4.340）

216.Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi S, Sumida T.:
Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Clin. Exp. Immunol. 164(2):236-247,2011(3.711)

217.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Toll-like receptor 7(TLR7) SNPs in the 3' untranslated region and intron additively contribute to susceptibility to systemic lupus erythematosus in a Japanese female population.
Arthritis Res. Ther. 13(2):R41,2011(4.148)

218.Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Cumulative Association of Eight Susceptibility Genes with Systemic Lupus Erythematosus in a Japanese Female Population.
Journal of Human Genetics 56:503-507,2011(3.545)

219.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, Kanamori A, Ochiai N, Miyazawa K, Sugihara M, Hayashi T, Goto D, Ito S, Sumida T.:
Six-transmembrane epithelial antigen of prostate4(STEAP4) is TNFalpha-induced protein that regulates IL-6, Il-8, and cell proliferation in synovium from patients with rheumatoid arthritis
Mod. Rheumatol.22:128-136,2012(1.973)

220.Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M, Hayashi T, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
Overexpression of T-bet gene regulates murine autoimmune arthritis
Arthritis Rheum.64(1):162-172,2012(9.002)

221.Tsuboi H, Nakamura Y, Iizuka M, Matsuo N, Matsumoto I, Sumida T.:
Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor
Mod. Rheumatol 22(2):264-271,2012(1.973)

222.Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota Y, Toshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D.:
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
Mod. Rhumatol 22:1-14,2012(1.973)

223.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, Sugihara M, Hayashi T, Ito S, Sumida T.
Six-transmembrane epithelial antigen of prostate4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.30(1):99-102,2012(3.238)

224.Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T,  Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H.:
Comprehensive Diagnostic Criteria (CDC criteria) for IgG4-related disease (IgG4-RD),2011.
Mod. Rhumatol 22:21-30,2012.(1.973)

225.Hasebe N, Kawasaki A, Ito I, Kawamoto M, Hasegawa M, Fujimoto M, Furukawa H, Tohma S, Sumida T, Takehara K, Sato S, Kawaguchi Y, Tsuchiya N.:
Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population.
Ann Rheum Dis.71(7):1259-60,2012(14.299)

226.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Lupus 21(8):890-5.2012(2.924)

227.Okada Y, Shimane K, Kochi Y, Tahira T, Suzuki A, Higasa K, Takahashi A, Horita T, Atsumi T, Ishii T, Okamoto A, Fujio K, Hirakata M, Amano H, Kondo Y, Ito S, Takada K, Mimori A, Saito K, Kamachi M, Kawaguchi Y, Ikari K, Mohammed W O, Matsuda K, Terao C, Ohmura K, Myouzen K, Hosono N, Tsunoda T, Nishimoto N, Mimori T, Matsuda F, Tanaka Y, Sumida T, Yamanaka H, Takasaki Y, Koike T, Horiuchi T, Hayashi K, Kubo M, Kamatani N, Yamada R, Nakumura Y, Yamamoto K.:
A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus erythematosus in Japanese.
PLoS Genet. 8(1),2012(5.224)

228.Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nagasawa H, Amano K, Nakajima A, Atsumi T, Koike T, Ihata A, Ishigatubo Y, Saito K, Tanaka Y, Ito S, Sumida T, Tohma S, Tamura N, Fujii T, Sugihara T, Kawakami A, Hagino N, Ueki Y, Hashiramoto A,  Nagasaka K, Miyasaka N,  Harigai M, for the REAL Study Group:
Time-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients
Arthritis Care Res. 64(8):1125-1134,2012(4.530)

229.Sakai R, Tanaka M, Nanki T, Watanabe K, Yamazaki H, Koike R, Nagasawa H, Amano K, Saito K, Tanaka Y, Ito S, Sumida T, Ihata A, Ishigatsubo Y, Atsumi T, Koike T, Nakajima A, Tamura N, Fujii T, Dobashi H, Tohma S, Sugihara T, Ueki Y, Hashiramoto A, Kawakami A, Hagino N, Miyasaka N, Harigai M, for the REAL Study Group.:
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anti-cytokine therapy with different target molecules.
Ann Rheum Dis 71(11):1820-1826, 2012(14.299)

230.Hashizume M, Yoshida H, Tanaka K, Suzuki M, Matsumoto I, Sumida T, Mihira M.:
Interleukine-6 regulates anti-arthritic effect of methotrexate via the reduction of SLC19A1 expression in mouse arthritis model.
Arthritis Res Ther 14(2):R96,2012(4.148)

231.Yamaguchi T, Ito S, Takano Y, Umeda N, Goto M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A case of a disseminated sporotrichosis patient treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis.
Intern. Med.51(15):2035-9,2012(0.956)

232.Anami A, Fukushima K, Takasaki Y, Sumida T, Waguri M, Murashima A, Wake N.:
The predictive value of SS-A antibody titration in pregnant women with fetal congenital heart block.
Mod Rhumatol 23(3):430-9,2013(1.973)

233.Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
Analysis of IgG4 class switch-related molecules in IgG4-related disease.
Arthritis Res. Ther. 14(4):R171,2012(4.148)

234.Ishiguro N, Yamamoto K, Katayama, K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Hara M, Iguratimod-Clinical Study Group:
Concomitant iguratimod theraphy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-bline, placebo-controlled trial.
Mod. Rhumatol 23(3):430-439,2013(1.973)

235.Inoue A, Matsumoto I, Tanaka Y, Umeda N, Tanaka Y, Mihara M, Takahashi S, Sumida T. :
TIARP (TNFAIP9) deficiency leads to arthritis via IL-6 overproduction with enhanced NF-kB, STAT3 signaling and dysregulated apoptosis of macrophages.
Arthritis Rheum 64(12):3877-85,2012(9.002)

236.Shimane K, Kochi Y, Suzuki A, Okada Y, Tomonori I, Horita T, Saito K, Okamoto A, Nishimoto N, Myouzen K, Hirakata M, Sumida T, Takasaki Y, Yamada R, Kamatani N, Nakamura Y, Kubo M, Yamamoto K.:
An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.
Rheumatology 52(7):1172-82,2013(5.149)

237.Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
Mod. Rheumatol 23(4):782-7,2013(1.973)

238.Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I.：
0Pathogenic role of anti-M3muscarinic acetylcholine receptor immune response in Sjogren's syndrome.
Presse Med.41(9 Pt 2):e461-6,2012(1.167)

239.Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, Matsumoto I, Sumida T.:
The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren's syndrome-like sialadenitis.
Mod. Rheumatol 23(3):614-6, 2013(1.973)

240.Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome.
Mod. Rheumatol 23(5): 841-5, 2013(1.973)

241.Horikoshi M, Goto D, Segawa S, Yoshiga Y, Iwanami K, Inoue A, Tanaka Y, Matsumoto I, Sumida T.:
Activation of invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
PLoS One 7(12):e51215,2012(2.776)

242.Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tanaka Y, Tsuboi H, Suzuki T, Hayashi T, Ito S, Tsuchiya N, Sumida T.:
Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Clin Exp Immunol 172(1):44-53,2013(3.711)

243.Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Validation of different sets of criteria for the diagnosis of Sjogren's syndrome in Japanese patients.
Mod. Rheumatol 23(2):219-25, 2013(1.973)

244.Ito S,Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T.:
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Mod Rheumatol 21(1):52-59,2014(1.973)

245.Furukawa H, Kawasaki A, Oka S, Shimada K, Masui T, Ikenaka T, Hashimoto A, Okazaki Y, Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A, Chiba N, Suematsu E, Fukui N, Hashomoto H, Sumida T, Ono M, Tsuchiya N, Tohma S:
Association of a Single Nucleotide Polymorphism in the SH2D1A Intronic Region with Systemic Lupus Erythematosus.
Lupus 22(5):497-503,2013(2.924)

246.Ogishima H, Tsuboi H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Suzuki T, Matsumoto I, Sumida T:
Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
Mod Rheumatol 24(1)60-68,2014(1.973)

247.Yoon J, Sudo K, Han J, Chae M, Park S, Weinstein M, Nakae S, Yamashita T, Lee , Sumida T, Kuroda M, Mamura M:
Smad2 is the TGF-β receptor-regulated Smad to suppress the immunogenicity of mouse and human dendritic cells.
Eur J Immunol(in press)(4.695)

248.Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Takai C, Hirota T, Asashima H, Miki H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Ogishima H, Suzuki T, Hiraoka T, Kaji Y, Matsumoto I, Ohshika T, Sumida T.:
Clinicopathological features of IgG4-related disease complicated with orbital involvement.
Mod Rheumatol 24(3):471-6,2014(1.973)

249.Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T.:
Primary and secondary surveys on epidemiology of Sjogren's syndrome in Japan.
Mod Rheumatol 24(3):464-70,2014(1.973)

250.Kawasaki A, Inoue N, Ajimi C, Sada K, Kobayashi S, Yamada H, Furukawa H, Sumida T, Tohma S, Miyasaka N, Matsuo S, Ozaki S, Hashimoto H, Makino H, Harigai M, Tsuchiya N.:
Association of IRF5 polymorphism with MPO-ANCA positive vasculitis in a Japanese population.
Genes Immun 14(8):527-9,2013(2.631)

251.Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M.:
Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing Eomesodermin in cytotoxic T lymphocytes.
EMBO Mol Med 5(11):1720-39,2013(10.624)

252.Ikeda K, Seto Y, Natita A, Kawakami A, Kawahito Y, Ito H, Matsushita I, Ohno S, Nishida K, Suzuki T, Kaneko A, Ogasawara M, Fukae J, Henmi M, Sumida T, Kamishima T, Koike T, JCR-CoSMUS :
Ultrasound assessment of synovial pathologies in rheumatoid arthritis using comprehensive multi-plane images of the 2nd metacarpophalangeal joint.
Arthritis Rheum 66(3):523-32,2014(9.002)

253.Hara M, Ishiguro N, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Yamamoto K; Iguratimod-Clinical Study Group.:
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial.
Mod Rheumatol 24(3):410-8,2014(1.973)

254.Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. :
The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: A Critical Review
J Autoimmunity 51:44-50,2014(7.543)

255.Gazal S, Sacre K, Allanore Y, Teruel M, Goodall AH, Tohma S, Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, Rodriguez-Rodriguez L, Chioccia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez-Gay MA, Furukawa H, Cantagrel A, Le Loet X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S, Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L, Martin J, Tsuchiya N, Dieud P.:
Identification of Secreted Phosphoprotein 1 Gene as a new Rheumatoid Arthritis Susceptibility Gene.
Ann Rheum Dis 74(3):e19,2015(14.299)

256.Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dorner T, Bootsma H, Tzioufas A, Solans Laque R, Mandl T, Gottenberg JE, Hachulla E, Moser K, Ng WF, Fauchais AL, Bombardieri S, Valesin G, Gerli R, Bartoloni E, Saraux A, Praprotnik S, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ.:
Validation of EULAR primary Sjogren's Syndrome disease activity and patient indexes.
Ann Rheum Dis 74(5):859-66,2015(14.299)

257.Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohara S, Setoguchi K, Kono Hm Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S.:
Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
PLoS One 9(2):e87792,2014(2.776)

258.Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
M3 muscarinic acetylcholine receptor reactive IL-17- producing T cells promotes development of Sjogren's syndrome like sialadenitis.
Mod Rheumatol 25(1):158-60, 2015(1.973)

259.Sumida T, Tsuboi H, Asashima H, Iizuka M, Matsumoto I.:
Highlights from the 12th International Symposium on Sjogren's Syndrome in Kyoto, Japan.
Sjogren's Quarterly 9(1):8-14,2014

260.Hagiwara S, Tsuboi H, Hagiya C, Yokosawa M, Hirota T, Ebe H, Takahashi H, Ogishima H, Asashima H, Kondo Y, Umeda N, Suzuki T, Hitomi S, Matsumoto I, Sumida T.:
Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.
Intractable Rare Dis Res 3(1):25-28,2014

261.Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.：
Involvement of CD161+Vδ1+γδT cells in systemic sclerosis: Association with interstitial pneumonia.
Rheumatology(Oxford) 53(12):2259-69,2014(5.149)

262.Matsumoto I, Inoue A, Takai C, Umeda N, Tanaka Y, Kurashima Y, Sumida T.:
Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIP) 3 and 9 in arthritis.(Review)
Clin Immunol 153(1):73-8,2014(3.548)

263.Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T.:
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
Mod Rheumatol 25(1):105-9,2015(1.973)

264.Tanaka Y, Matsumoto I, Inoue A, Umeda N, Takai C, Sumida T.:
Antigen-specific overexpression of human cartilage glycoprotein 39 on CD4+CD25+Foxp3+ Treg cells in the generation of glucose-6-phosphate isomerase induced arthritis.
Clin Exp Immunol 177(2):419-27,2014(3.711)

265.Tsuboi H, Ohira H, Asashima H, Tsuzuki S, Iizuka M, Matsuo N, Kondo Y, Matsumoto I, Sumida T.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
Hepatol Res 44(14):E471-9,2014(3.440)

266.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T, Takaiwa F.:
Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
Biosci Biotech Bioch 78(10):1662-8,2014(1.297)

267.Sakai R, Cho SK, Nanki T, Koike R, Watanabe K, Yamazaki H, Nagasawa H, Amano K, Tanaka Y, Sumida T, Ihata A, Yasuda S, Nakajima A, Sugihara T, Tamura N, Fujii T, Dobashi H, Miura Y, Miyasaka N, Harigai M, the REAL study group:
The risk of serious infection in patients with rheumatoidarthritis treated with tumor necrosis factor inhibitorsdecreasedovertime: a report from the registry of Japanese rheumatoid arthritis patientsfor long-term safety (REAL) database.
Rheumatol Int 34(12):1729-36,2014(2.200)

268.Hirota T, Suzuki T, Hagiwara S, Ogishima H, Matsumoto I, Sumida T.:
Analysis of the usefulness of magnetic resonance imaging evaluation for rheumatoid arthritis treated with biological agents in the early phase: Retrospective observation of abatacept and infliximab.
Clin Exp Rheumatol 32(6):991,2014(3.238)

269.Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T.:
DNA microarray analysis of labial salivary glands in IgG4-related disease. Comparison with Sjogren's syndrome.
Arthritis Rheum 66(10):2892-9,2014(9.002)

270.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Plant Biotechnol J 12:(8):1143-53,2014(6.840)

271.Tanaka K, Shiota j, Mikami M, Inoue Y, Sumida T, Matsumoto I, Muramoto K.:
The combined effects of iguratimod with anti-TNFα antibody on experimental arthritis models in mice.
Inflamm Regen 34(3):157-164,2014

272.Suzuki T, Hirota T, Ogishima H, Umeda N, Kondo Y, Yokosawa M, Miki H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for two years.
Int J Rheum Dis 18(1):108-10,2015(1.938)

273.Terao C, Yamada R, Mimori T, Yamamoto K, Sumida T.;
A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex.
Lupus 23(13):1435-42,2014(2.924)

274.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial. An open label, one-year, prospective study. Interim analysis of 32 patients for 24 weeks.
Mod Rheumatol 25(2):187-93,2015(1.973)

275.Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H, Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
Usefulness of MR imaging of the parotid glands in patients with secondary Sjogren’s syndrome associated with rheumatoid arthritis.
Mod Rheumatol 25(3):415-20,2015(1.973)

276.Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Satoru T, Sibayama S, Matsumoto I, Sumida T. :
T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice..
Clin Exp Immunol 179(2):197-209,2015(3.711)

277.Kawasaki A, Furukawa H, Nishida N, Warabi E, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Nagaoka S, Setoguchi K, Nagai T, Hirohata S, Shimada K, Sugai S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Okamoto A, Kono H, Tokunaga K, Takasaki Y, Hashimoto H, Sumida T, Tohma S, Tsuchiya N.:
Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: a Case-Control Association Study.
PLoS One 9(10):e109764,2014(2.776)

278.Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, Sumida T.:
Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan.
Mod Rheumatol 25(3):393-400,2015(1.973)

279.Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
Predictors of the response to treatment in acute lupus 1 hemophagocytic syndrome.
Lupus 24(7):659-68,2015(2.924)

280.Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, Hayashida J, Ohta M, Saeki T, Notohara K, Sumida T, Nakamura S.:
Polarized M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.
Clin Immunol 156(1):9-18,2015(3.548)

281.Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto I, Sumida T.:
A crucial role of RORgt in the development of spontaneous sialadenitis-like Sjogren's syndrome.
J Immunol 194(1):56-67,2015(4.718)

282.Kurata I, Tsuboi H, Takahashi H, Inoue S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
Behcet's disease on hemodialysis and a review of literature for infliximab use on hemodialysis.
Intern Med 54(12):1553-7,2015(0.956)

283.Seror R, Bootsma H, Saraux A, Bowman S J, Theander E, Brun J G, Baron G, Leguern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dorner T, Tzioufas A, Gottenberg J-E, Laque R S, Mandl T, Hachulla E, Sivils K L, Ng W-F, Fauchais A-L, Bombardieri S, Valesini G, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize A A, Vollenveider C, Ravaud P, Meiners P, Brito-Zeron P, Vitali C, Mariette X.:
Defining disease activity sates and meaningful differences in primary Sjogren's Syndrome with EULAR primary Sjogren's Syndorome disease activity(ESSDAI) and patient reported indexes(ESSPRI).
Ann Rheum Dis 75(2)382-389,2016(14.299)

284.Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S, Asashima H, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:
[18F]fluorodeoxyglucose positron emission tomography/computed tomography can reveal subclinical prostatitis in a patient with IgG4-related disease..
Rheumatology (Oxford) 54(6):1113,2015(5.149)

285.Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus
successfully treated by corticosteroid and methotrexate.
Rheumatology (Oxford) 54(7):1160,2015(5.149)

286.Takai C, Matsumoto I, Inoue A, Umeda N, Tanaka Y, Kurashima Y, Wada Y, Narita I, Sumida T.:
Specific overexpression of TNFAIP9 in CD14+CD16- monocytes in patients
with rheumatoid arthritis- Comparative analysis with TNFAIP3.
Clin Exp Immunol 180(3):458-66,2015(3.711)

287.Kato M, Chino Y, Sato R, Kinoshita K, Tsuji H, Tokuda Y, Tamaoka A, Sumida T.:
Lateral medullary infarction in a patient with central nervous system lupus.
Int J Rheum Dis 18(1):108-10,2015(1.938)

288.Kondo Y, Yao Z, Tahara M, Izuka M, Yokosawa M, Kaneko S, Segawa S, Tsuboi H, Yoh K, Takahashi S, Matsumo I, Sumida T.:
Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
Arthritis Res Ther 17(1):105,2015(4.148)

289.Miki H, Nakahashi-Oda C, Sumida T, Sibuya A.:
Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses.
J Immunol 194(11):5069-76,2015(4.718)

290.Asashima H, Tsuboi H, Iizuka M, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+ T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome.
Arthritis Rheum 67(8):2213-25,2015(9.002)

291.Yoon JH, Sudo K, Kuroda M, Kato M, Lee I, Nakae S, Imamura T, Kim J, Ju JH, Matsuzaki K, Matsumoto I, Sumida T, Mamura M.:
Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation.
Nat Commun 21;6:7600,2015(11.880)

292.Ogata A, Atusmi T, Fukada T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, MSc, and the MUSASHI Study Investigators:
Results of switching from intravenous to subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis: Extension of the MUSASHI study.
Arthritis Care Res 67(10):1354-62,2015(4.530)

293.Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.:
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
PLoS One 10(5):e0126582,2015(2.776)

294.Tanaka Y, Takeuchi T, Miyasaka N, Sumida T, Mimori T, Koike T, Endo K, Mashino N, Yamamoto K.:
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus including lupus nephritis who are refractory to conventional therapy.
Mod Rheumatol 26(1):80-6,2016(1.973)

295.Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Evaluation of changes in magnetic resonance images following 24 and 52 weeks treatment of rheumatoid arthritis with infliximab, tocilizumab or abatacept.
Mod Rheumatol 26(1):29-35,2016(1.973)

296.Murayama MA, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, Tateishi K, Ishigame H, Yabe R, Ikeda S, Seno A, Chi HH, Hashiguchi Y, Kurata R, Tada T, Kubo S, Sato N, Liu Y, Hattori M, Saijo S, Matsushita M, Fujita T, Sumida T, Iwakura Y.:
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.
Nat Commun 25;6:8483,2015(11.880)

297.Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Scand J Rheumatol 44(6):511-3,2015(2.706)

298.Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K, Yamamoto K.:
Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
Sci Rep 21;5:13041,2014(4.011)

299.Ikeda K, Narita A, Ogasawara M, Ohno S, Kawahito Y, Kawakami A, Ito H, Matsushita I, Suzuki T, Misaki K, Ogura T, Kamishima T, Seto Y, Nakahara R, Kaneko A, Nakamura T, Henmi M, Fukae J, Nishida K, Sumida T, Koike T.:
Consensus-based identification of factors related to false-positives in ultrasound scanning of synovitis and tenosynovitis.
Mod Rheumatol 26(1):9-14,2016(1.973)

300.Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T, Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Clin Rheumatol 35(5):1181-8,2016(2.293)

301.Tsuboi H, Sumida T, Noma H, Yamagishi K, Anami A, Fukushima K, Horigome H, Maeno Y, Kishimoto M, Takasaki Y, Nakayama M, Waguri M, Sago H, Murashima A.:
Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
Mod Rheumatol 26(4):569-75,2016(1.973)

302.Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
A case of refractory Kimura disease with a buccal bulky mass successfully treated with
low-dose cyclosporine A: report and review of the literature.
Allergol Int 65(2):212-4,2016(3.965)

303.Celi Sun C, Molineros J, Looger L, Kim K, Zhou XJ, Kim-Howard X, Motghore P, Bhattarai K, Adler A, So-Young Bang SY, Lee HS, Kim TH, Kang YM, Suh CH, Chung WT, Park YB, Choe JY, Shim SC, Lee SS, Han BG, Dozmorov M, Wren J, Harley J, Chua KH, Zhang H, Bae SC, Jin KimYJ , Okada Y, Kochi Y, Suzuki A, Kubo M, Sumida T, Yamamoto K, Shen N, Ma J, Qi YY, Kaufman K.:
High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry.
Nat Genet 48(3):323-30,2016(25.455)

304.Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, Hayashida J, Yamauchi M, Ishiguro N, Miakami Y, Tsuboi H, Iizuka-Koga M, Kawano S, Sato Y, Kiyoshima T, Sumida T, Nakamura S.:
DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate immune related proteins.
Medicine 95(7):e2853,2016(1.870)

305.Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata I, Ohyama A, Yagishita M, Abe S, Kurashima Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
Mod Rheumatol 26(6):857-862,2016(1.973)

306.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Effectiveness of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial.
Mod Rheumatol 26(6):891-899,2016(1.973)

307.Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
The regulatory role of IFN-producing gammadelta T cells via the suppression of Th17 cell activity in bleomycin-induced pulmonary fibrosis.
Clin Exp Immunol(in press)(3.711)

308.Furukawa H, Oka S, Kawasak A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N. :
Human leukocyte antigen and systemic sclerosis in Japanese: The sign of the four independent protective alleles, DRB1*13:02, DRB1*14:06,　DQB1*03:01, and DPB1*02:01.
PLoS One 11(4):e0154255,2016(2.776)

309.Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.:
Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
PLoS One 11(5):e0154393,2016(2.776)

310.Hamaguchi Y, Sumida T, Kawaguchi Y, Ihn H, Tanaka S, Asano Y, Motegi SI, Kuwana M, Endo H, Takehara K.:
Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.
J Dermatol 44(1):13-17,2017(3.377)

311.Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N.:
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: a Case-control Association Study.
PLoS One 11(6):e0158065,2016(2.776)

312.Ishiguro N, Atsumi T, Harigai M, Mimori T, Nishimoto N, Sumida T, Takeuchi T, Tanaka Y, Nakasone A, Takagi N, Yamanaka H:
Effectiveness and Safety of Tocilizumab in Achieving Clinical and Functional Remission, and Sustaining Efficacy in Biologic-Naive Patients With Rheumatoid Arthritis: The FIRST Bio Study.
Mod Rheumatol 27(2):217-226,2017(1.973)

313.Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M, Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of
glucose-6-phosphate-isomerase.
Mod Rheumatol 27(3):457-465,2017(1.973)

314.Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
Clin Exp Immunol 187(2):213-224,2017(3.711)

315.Inoue A, Matsumoto I, Tanaka Y, Umeda N, Takai C, Kawaguchi H, Ebe H, Yoshida H, Matsumoto Y, Segawa S, Takahashi S, Sumida T.:
TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
Sci Rep 6:38684,2016(4.011)

316.Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami HI, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.:
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.
Mod Rheumatol 27(5):849-854,2017(1.973)

317.Yokosawa M, Kondo Y, Tahara M, Iizuka M, Segawa S, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFNγ-independent pathway.
Clin Exp Immunol 188(1):22-35,2017(3.711)

318.Umeda N, Matsumoto I, Tanaka Y, Kawaguchi H, Ebe H, Kagami Y, Ishigami A, Sumida T.:
Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide -7 (CCG-7) antibodies were suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in the RA synovium.
Mod Rheumatol 27(5):914-916,2017(1.973)

319.Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful cases utilizing both corticosteroids and an upfront combination of vasodilators.
Modern Rheumatol Case Reports 1(2):73-78,2017

320.Furukawa S, Moriyama N, Miyake K, Nakashima H, Tanaka A, Maehara T, Iizuka-Koga M, Tsuboi H, Hayashida JN, Ishiguro N, Yamauchi M, Sumida T, Nakamura S.:
Interleukin-33 produced by M2 macrophages and other immune cells contributes to immune reaction of IgG4-related disease.
Sci Rep 7:42413,2017(4.011)

321.Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Comparison of the performance of new ACR-EULAR classification criteria for primary Sjogren's syndrome with former sets of criteria in Japanese patients.
Ann Rheum Dis 76(12):1980-1985,2017(14.299)

322.Iizuka-Koga M, Asashima H, Ando M, Lai C-Y, Mochizuki S, Nakanishi M, Nishimura T, Tsuboi H, Hirota T, Takahashi H, Masumoto I, Otsu M, Sumida T.:
Functional analysis of dendritic cells generated from T-iPS cells from CD4+ T cell clones of Sjogren's syndrome.
Stem Cell Rep 8(5):1155-1163,2017(5.499)

323.Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of recurrent Kikuchi-Fujimoto disease successfully treated by concomitant use of hydroxychloroquine and corticosteroid.
Intern Med 56(24):3373-3377,2017(0.956)

324.Nitta T, Kochi Y, Muro R, Tomofuji Y, Okamura T, Murata S, Suzuki H, Sumida T, Yamamoto K, Takayanagi H.:
Human thymoproteasome variations impact CD8 T cell selection and autoimmunity.
Science Immunol 2(12). pii: eaan5165,2017(10.551)

325.Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
Clin Exp Immunol 190(1):96-109,2017(3.711)

326.Lin SY, Matsuno Y, Yokosawa M, Suzuki T, Morishima Y, Sakamoto T, Sumida T, Hizawa N.
Analysis of scrub typhus involvement of the lung by bronchoalbeolar lavage: A case report.
Respir Investig 54(6):487-489,2016(1.770)

327.Takahashi H, Tsuboi H, Yokosawa M, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjogren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
Mod Rheumatol 28(2):300-307,2018(1.973)

328.Kawaguchi H, Tsuboi H, Yagishita M, Terasaki T, Terasaki M, Shimizu M, Honda F, Ohyama A, Takahashi H, Miki H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
A case of severe adult-onset Still disease with constrictive pericarditis and pleuritis successfully treated with tocilizumab in addition to corticosteroid and cyclosporin A.
Intern Med 57(7):1033-1038,2018(0.956)

329.Kawasaki A, Yamashita K, Hirano F, Sada KE, Tsukui D, Kondo Y, Kimura Y, Asako K, Kobayashi S, Yamada H, FurukawaH, Nagasaka K, Sugihara T, Yamagata K, Sumida T, Tohma S, Kono H, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.
Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.
J Hum Genet 63(1):55-62,2018(3.545)

330.Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mirori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
Mod Rheumatol 28(4):642-648,2018(1.973)

331.Fujita-Tanaka H, Ogawa Y, Muro Y, Ogawa-Momohara M, Asashima H, Tsuboi H, Sumida T, Akiyama M.
Pansclerotic morphea associated with hypohidrosis and anti-M3 muscarinic acetylcholine receptor antibodies.
Br J Dermatol 178(3):e210-e211,2018(6.714)

332.Ebe H, Matsumoto I, Kawaguchi H, Kurata I, Tanaka Y, Inoue A, Kondo Y, Tsuboi H, Sumida T.
Clinical and functional significance of STEAP4-splice variant in CD14⁺ monocytes in patients with rheumatoid arthritis.
Clin Exp Immunol 191(3):338-348,2018(3.711)

333.Kondo Y, Yokosawa M, Kaneko S, Furuyama K, Segawa S, Tsuboi H, Matsumoto I, Sumida T.
Transcriptional regulation of CD4+ T cell differentiation in experimentally-induced arthritis and rheumatoid arthritis.
Arthritis Rheum 70(5):653-661,2018(9.002)

334.Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, Oyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.
A case of clinically amyopathic dermatomyositis with interstitial pneumonia successfully treated with plasma exchange.
Intern Med 57(13):1935-1938,2018(0.856)

335.Kaneko S, Kondo Y, Yokosawa M, Furuyama K, Segawa S, Tsuboi H, Kanamori A, Matsumoto I, Yamazaki M, Sumida T.:
The RORgt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
Mod Rheumatol 70(5):653-661,2018(1.973)

336.Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovsk? J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.:
Splicing variant of WDFY4 augments MDA5 signaling and the risk of clinically amyopathic dermatomyositis.
Ann Rheum Dis 77(4):602-611,2018(14.299)

337.Honda F, Tsuboi H, Toko H, Terasaki T, Terasaki M, Shimizu M, Ohyama A, Yagishita M, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
Contrast enhanced computed tomography revealed gallbladder hemorrhage due to active vasculitis in a patient with microscopic polyangiitis.
J Clin Rheumatol 25(6):e84-e85,2019(1.897)

338.Takahashi H, Tsuboi H, Umeda N, Toko H, Honda F, Ohyama A, Abe S, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Hirose Y, Hara A, Sumida T.:
A case of otitis media with ANCA-associated vasculitis accompanied with pituitary mass successfully treated by corticosteroids.
Modern Rheumatol Case Reports 2(2)185-190,2018

339.Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I,Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nshiyama,S Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H.:
Clinical practice guideline for Sjogren's syndrome 2017.
Mod Rheumatol 28(3):383-408,2018(1.973)

340.Toko H, Tsuboi H, Umeda N, Honda F, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of intractable hemophagocytic syndrome associated with systemic lupus erythematosus resistant to corticosteroids and intravenous cyclophosphamide that was successfully treated by cyclosporine A.
Intern Med 57(18):2747-2752,2018(0.956)

341.Kawaguchi H, Matsumoto I, Osasda A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Shinkai Y, Kumagai Y, Ishigami A, Sumida T.:
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Arthritis Res Ther 20(1):66,2018(4.148)

342.Ohyama A, Tsuboi H, Noma H, Terasaki M, Shimizu M, Toko H, Honda F, Yagishita M, Takahashi H, Asasahima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases.
Mod Rheumatol 29(2):344-350,2019(1.973)

343.Kohsaka H, Mimori T, Kanda T, Shimizu J, Sunada Y, Fujimoto M, Kawaguchi Y, Jinnin M, Muro Y, Ishihara S, Tomimitsu H, Sumida T.:
Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists, and dermatologists in Japan.
Mod Rheumatol 29(1):1-19,2019(1.973)

344.Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Funakubo-Asanuma Y, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T.:
Evidence-based clinical practice guideline for adult Still's disease.
Mod Rheumatol 28(5):736-757,2018(1.973)

345.Shimizu M, Asashima H, Terasaki M, Toko H, Honda F, Ohyama A, Yagishita M, Takahashi H, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Renal Sarcoidosis With Multiple Organ Involvement.
J Clin Rheumatol 26(3):e55,2020(1.897)

346.Ebe H, Matsumoto I, Osada A, Kurata I, Kawaguchi H, Kondo Y, Tsuboi H, Sumida T.:
Splice variant of STEAP4 localizes in the nucleus, making it a possible transcriptional regulator of IL-6 production.
Mod Rheumatol 29(4):714-716,2019(1.973)

347.Shiraishi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazawaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T.
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.
Sci Rep8(1):10262,2018(4.011)

348.Nakamagoe K, Yanagiha H, Miyake Z, Kondo Y, Hiyama T, Ishii A, Kaji Y, Oshika T, Sumida T, Tamaoka A.
Monocular Oculomotor Nerve Disorder Manifesting as Cranial Neuropathy in Systemic Lupus Erythematosus: A Case Report.
Intern Med 57(23):3445-3449,2018(0.956)

349.Iizuka A, Segawa S, Kondo Y, Kaneko S, Yokosawa M, Furuyama K, Miki H, Tahara-Hanaoka S, Shibuya A, Tsuboi H, Goto D, Matsumoto I, Shibayama S, Sumida T.:
Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
Int J Rheum Dis 21(12):2071-2078,2018(1.938)

350.Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.:
Placenta specific-8 suppresses IL-18 production through regulation of autophagy and is associated with Adult Still’s disease.
J Immunol 201(12):3535-3545,2018(4.718)

351.Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Ishigami A, Sumida T.:
Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interlukin-6.
Mod Rheumatol 29(6):964-969,2019(1.973)

352.Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F, Ohyama A, Yagishita M, Osada A, Kaneko S, Ebe H, Kawaguchi H, Takahashi H, Hagiwara S, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Effect of biological disease modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis.
Intern Med 58(12):1703-1712,2019(0.956)

353.Akizuki S, Ishigaki K, Kochi Y, Law S-M, Matsuo K, Ohmura K, Suzuki A, Nakayama M, Iizuka Y, Koseki H, Ohara O, Hirata J, Kamatani Y, Matsuda F, Sumida T, Yamamoto K, Okada Y, Mimori T, Terao C.:
PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune-phenotypes.
Ann Rheum Dis 78(4):509-51,2019(14.299)

354.Takamuki R, Okiyama N, Inoue S, Endo R, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Kondo Y, Chino Y, Sumida T, Fujimoto M.
Successful treatment of refractory cutaneous lupus vasculitis with i.v. immunoglobulin.
J Dermatol 46(7):e253-e255,2019(3.377)

355.Namba N, Kawasaki A, Sada K, Hirano F, Kobayashi S, Yamada H, Furukawa H, Shimada K, Hashimoto A, Matsui T, Ngasaka K, Sugihara T, Suzuki A, Yamagata K, Sumida T, Tohma S, Homma S, Ozaki S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N, On behalf of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS):
Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.
Ann Rheum Dis 78(8):1144-1146,2019(14.299)

356.Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakaramura S, Sumida T.
Up-regulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.
Mod Rheumatol 30(4):729-737,2020(1.973)

357.Furukawa H, Oka S, Kawasaki A, Hidaka M, Shimada K, Kondo Y, Ihata A, Matsushita T, Matsumoto T, Hashimoto A, Matsumoto I, Komiya A, Kobayashi K, Osada A, Katayama M, Okamoto A, Setoguchi K, Kono H, Hamaguchi Y, Matsui T, Fukui N, Tamura H, Takehara K, Nagaoka S, Sugii S, Sumida T, Tsuchiya N, Tohma S.:
Human Leukocyte Antigen in Japanese patients with idiopathic inflammatory myopathy.
Mod Rheumatol 30(4):696-702,2020(1.973)

358.Kurata I, Matsumoto I, Ohyama A, Osada A, Ebe H, Kawaguchi H, Kaneko S, Kondo Y, Tsuboi H, Tomioka A, Kaji H, Sumida T.:
Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis..
Ann Rheum Dis 78(11):1488-1496,2019(14.299)

359.Hagiwara S, Tsuboi H, Terasaki T, Terasaki M, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis.
Mod Rheumatol 30(2):365-372,2020(1.973)

360.Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H.:
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.
Mod Rheumatol 30(3):551-557,2020(1.973)

361.Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T.:
Pathogenesis of IgG4-related disease. Comparison with Sjogren's syndrome.
Mod Rheumatol 30(1):7-16,2020(1.973)

362.Matsumoto I, Kurata I, Ohyama A, Kawaguchi H, Ebe H, Osada A, Kondo Y, Tsuboi H, Sumida T.:
Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.
Mod Rheumatol 30(2):232-238,2020(1.973)

363.Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T.:
Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjogren's syndrome.
Mod Rheumatol 30(5):884-893,2020(1.973)

364.Sato R, Takahashi H, Terasaki M, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Advantage of magnetic resonance imaging in detecting tracheal involvement and evaluation of the therapeutic effect in relapsing polychondritis with asthma-like symptoms.
J Clin Rheumatol 27(3):e90-e91,2021(1.897)

365.Terasaki M, Takahashi H, Sato R, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Successful treatment with multitarget therapy of mycophenolate mofetil and tacrolimus for cyclophosphamide-resistant ANCA-associated pauci-immune glomerulonephritis developed independently of systemic lupus erythematosus.
J Clin Rheumatol 27(2):e79-e80,2021(1.897)

366.Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, Kanda T, Kawaguchi Y, Kawakami A, Mimori A, Mimori T, Mimura T, Muro Y, Sano H, Shimizu J, Takeuchi T, Tanaka Y, Yamamoto K, Sumida T, Kohsaka H, The Research Team for Autoimmune Disease, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare.:
The first external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR) / American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
Ann Rheum Dis 79(3):387-392,2020(14.299)

367.Yokoyama N, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Hirano F, Sada K-e, Matsumoto I, Kusaoi M, Amano H, Nagaoka S, Setoguchi K, Nagai T, Shimada K, Sugii S, Hashimoto A, Matsui T, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Migita K, Kono H, Hasegawa M, Kobayashi S, Yamada H, Nagasaka K, Sugihara T, Yamagata K, Ozaki S, Tamura N, Takasaki Y, Hashimoto H, Makino H, Arimura Y, Harigai M, Sato S, Sumida T, Tohma S, Takehara K, Tsuchiya N.:
Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis, but not with ANCA-associated vasculitis in a Japanese population.
Sci Rep 9(1):16366,2019(4.011)

368.Nishiyama T, Kondo Y, Okamoto S, Terasaki M, Toko H, Yagishita M, Takahashi H, Yokosawa M, Tsuboi H, Matsumoto I, Sumida T.:
Aortic arch aneurysm in Behcet disease successfully treated with infliximab.
Intern Med 59(8):1087-1091,2020(0.956)

369.Ono Y, Tsuboi H, Moriyama M, Asashima H, Kudo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Nakmura S, Matsumoto I, Sumida T.:
RORγt antagonist improves Sjogren's syndrome-like sialadenitis through downregulation of CD25.
Oral Dis 26(4):766-777,2020(2.625)

370.Miki H, Tahara-Hanaoka S, Almida MS, Hitomi K, Shibagaki S, Kanemaru K, Lin YH, Iwata K, Miyake S, Shibayama S, Sumida T, Shibuya K, Shibuya A.:
Allergin-1 immunoreceptor1 suppresses house dust mite-induced allergic airway inflammation.
J Immunol 204(4):753-762,2020(4.718)

371.Imamura M, Mukaino A, Takamatsu K, Tsuboi H, Higuchi O, Nakamura H, Abe S, Ando Y, Matsuo H, Nakamura T, Sumida T, Kawakami A, Nakane S.:
Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases.
Int J Mol Sci 21(4):1332,2020(4.183)

372.Morinaka S, Takano Y, Goto D, Sumida T.:
Familial HLA-B*52 vasculitis: Maternal, atypical Cogan’s syndrome with Takayasu arteritis-mimicking aortitis and filial Takayasu arteritis.
Intern Med 59(15):1899-1904,2020(0.956)

373.Okamoto S, Tsuboi H, Sato R, Terasaki T, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
Rheumatol Int 40(10):1725-1732,2020(2.200)

374.Yamashita K, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Okiyama N, Nagaoka S, Shimada K, Sugai S, Katayama M, Hirohata S, Okamoto A, Chiba N, Suematsu E, Setoguchi K, Migita K, Sumida T, Tohma S, Hamaguchi Y, Hasegawa M, Sato S, Kawaguchi Y, Takehara K, Tsuchiya N.:
Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
Rheumatology 59(11):3553-3562,2020(5.149)

375.Kurata I, Matsumoto I, Sumida T.:
T follicular helper cell subsets: a potential key player in autoimmunity.
Immunol Med 44(1):1-9,2021

376.Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Identification of M3 muscarinic acetylcholine receptor reactive Th17 cells in patients with primary Sjogren's syndrome.
JCI insight 5(15):e135982,2020(6.014)

377.Terasaki T, Kondo Y, Takahashi M, Tawara T, Fujita A, Yagi H, Kawai H, Noguchi M, Sato R, Terasaki M, Okamoto S, Toko H, Yagishita M,
Takahashi H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Therapeutic plasma exchange improved pregnancy-associated thrombotic microangiopathy but not pregnancy outcome in patient with systemic lupus erythematosus.
Intern Med 59(24):3235-3238,2020(0.956)

378.Tsuboi T, Suzuki H, Akutsu D, Terasaki T, Okamoto S, Kondo Y, Matsumoto I, Mizokami Y, Sumida T.:
The pathologically confirmed esophageal involvement of idiopathic multicentric Castleman’s disease mimicking early esophageal cancer.
Rheumatology(Oxford) 60(2):e50-e52,2021(5.149)

379.Yagishita M, Tsuboi H, Tabuchi D, Sugita T, Nishiyama T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases.
Mod Rheumatol 31(3):636-642,2021(1.973)

380.Baer A-N, Gottenberg J-E, Clar E-W, Sumida T, Takeuchi T, Seror R, Foulks, G, Nys M, Mukherjee S, Wong R, Ray N, Boostsma H.:
Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial.
Ann Rheum Dis 80(3):339-348,2020(14.299)

381.Kawasaki A, Namba N, Sada K, Hirano F, Kobayashi S, Nagasaka K, Sugihara T, Ono N, Fujimoto T, Kusaoi M, Tamura N, Yamagata K, Sumida T, Hashimoto H, Ozaki S, Makino H, Arimura Y, Harigai M, Tsuchiya N.:
Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study.
Arthritis Res Ther 22(1):246,2020(4.148)

382.Yin X, Kim K, Suetsugu H, Bang S-Y, Wen L, Koido M, Ha E, Liu L, Sakamoto Y, Jo S, Leng R-X, Otomo N, Laurynenka V, Kwon Y-C, Sheng Y, Sugano N, Hwang M-Y, Li W, Mukai M, Yoon K, Cai M, Ishigaki K, Chung W-T, Huang H, Takahashi D, Lee S-S, Wang M, Karino K, Shim S-C, Zheng X, Miyamura T, Kang Y-M, Ye D, Nakamura J, Suh C-H, Tang Y, Motomura G, Park Y-B, Ding H, Kuroda T, Choe J-Y, Li C, Niiro H, Park Y, Shen C, Miyamoto T, Ahn G-Y, Fei W, Takeuchi T, Shin J-M, Li K, Kawaguchi Y, Lee Y-K, Wang Y, Amano K, Yang W, Tada Y, Yamji K, Shimizu M, Atsumi T, Suzuki A, Sumida T, Okada Y, Matsuda K, Matsuo K, Kochi Y, Japanese Reseatch Committee on Idiopathic Osteonecrosis og the Femoral Head, Kottyan L-C, Weirauch M-T, Parameswaran S, Eswar S, Hanan S, Chen X, Yamamoto K, Harley J-B, Ohmura K, Kim T-H, Yang S, Yamamoto T, Kim B-J, Shen N, Ikegawa S, Lee H-S, Zhang X, Terao C, Cui Y, Bae S-C.:
Meta-analysis of 208,370 East Asians identifies 113 genomic loci and yields new non-immune cell relevant biological insights for systemic lupus erythematosus.
Ann Rheum Dis 80(5):632-40,2020(14.299)

383.Osada A, Matsumoto I, Mikami N, Ohyama A, Kurata I, Kondo Y, Tsuboi H, Ishigami A, Sano Y, Arai T, Ise N, Sumida T.:
Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Clin Exp Immunol 203(3):385-399,2021(3.711)

384.Morinaka S, Tsuboi H, Hagiwara S, Sugita T, Tabuchi D, Sato R, Nishiyama T, Okamoto S, Terasaki T, Yagishita M, Takahashi H, Kondo Y, Matsumoto I, Sumida T.:
Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset.
Mod Rheumatol (in press)(1.973)

385.Nishiyama T, Kondo Y, Tsuboi H, Noma H, Tabuchi D, Sugita T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Yagishita M, Abe S, Takahashi H, Osada A, Hagiwara S, Matsumoto I, Sumida T.:
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Mod Rheumatol (in press)(1.973)

386.Takahashi H, Tsuboi H, Abe S, Honda F, Kondo Y, Matsumoto I, Sumida T.:
Humanized NOD/SCID/IL2rγnull mice exhibit functionally augmented human regulatory T cells associated with enzymatic upregulation of H3K27me3 in comparison with humans.
Clin Exp Immunol 204(2):239-250,2021(3.711)

387.Okamoto S, Tsuboi H, Noma H, Tabuchi D, Sugita T, Nishiyama T, Terasaki T, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Predictive factors for pneumomediastinum during management of connective tissue diseaserelated interstitial lung disease: A retrospective study.
Intern Med (in press)(0.956)

388.Kurata I, Mikami N, Ohyama A, Osada A, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus.
Clin Exp Immunol (in press)(3.711)

389.Ohyama A, Osada A, Kawaguchi H, Kurata I, Nishiyama T, Iwai T, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Specific increase in joint neutrophil extracellular traps and its relation to interleukin 6 in autoimmune arthritis.
Int J Mol Sci (in press)(4.183)

390.Honda F, Tsuboi H, Ono Y, Abe S, Takahashi H, Ito K, Yamada K, Kawano M, Kondo Y, Asano K, Tanaka M, Mallsen M, Mallsen B, Matsumoto I, Sumida T.:
Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis.
Arthritis Res Ther (in press)(4.148)

391.Shimizu M, Kondo Y, Tanimura R, Furuyama K, Yokosawa M, Asashima H, Tsuboi H, Matsumoto I, Sumida T.:
T-bet represses collagen-induced arthritis by suppressing Th17 lineage commitment through inhibition of RORgt expression and function.
Sci Rep (in press)(4.011)

392.Furuyama K, Kondo Y, Shimizu M, Yokosawa M, Segawa S, Iizuka A, Tanimura R, Tsuboi H, Matsumoto I, Sumida T.:
RORγt⁺Foxp3⁺ regulatory T cells in the regulation of autoimmune arthritis.
Clin Exp Immunol (in press)(3.711)

393.Kitanaga Y, Yamajuku D, Kubo S, Nakamura K, Maeda M, Seki M, Kaneko Y, Kinugasa F, Morokata T, Kondo Y, Yoshinari H, Nakayamada S, Sumida T, Tanaka Y.:
Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus.
Int Immunopharmacol (in press)(4.932)

394.Kimura N, Sumida T, et al.
Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-center, randomized controlled trial.
Rheumatology (Oxford) (in press)(in press)(5.149)